Emma Jones, PharmD, BCOP

This abstract was presented at the Oncology Pharmacists Connect (OPC) meeting in Austin, Texas, from June 18 to 19, 2026.

A landscape overview of enfortumab vedotin’s expanding role across bladder cancer settings—from MIBC to earlier lines of therapy—with a focus on pharmacist-led patient support, AE management, and real-world implementation.

A landscape overview of enfortumab vedotin’s expanding role across bladder cancer settings — from MIBC to earlier lines of therapy — with a focus on pharmacist-led patient support, AE management, and real-world implementation.

Practical insights for navigating rare, high-stakes toxicities.

Oncology pharmacist Emma Jones, PharmD, BCOP, outlines how clinicians can recognize and manage these complex cases.